Vnitr Lek 2006, 52(5):451-453

Metabolic PPAR receptors and skin

Š. Svačina
III. interní klinika 1. lékařské fakulty UK a VFN, Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Activators of metabolic PPAR receptors are used in diabetology and lipidology. Many substance influancing PPAR (β/δ) are in research. These substances will be perhaps used in obesitology and in atherosclerosis treatment. Much quicker is approaching the use in dermatology. The effect of receptor stimulation will be used in wound healing and in the treatment of allergic and proliferative diseases. Some realeted substancies influencing heterodimers with RXR or RAR receptors are used in the treatment of acne and skin lymfomas. Dermatology will be after internal medicine the second field where influencing of PPAR receptors will be very important.

Keywords: PPAR β (δ); dermatology; wound healin; acne; skin allergy

Received: August 19, 2005; Accepted: August 19, 2005; Published: May 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svačina Š. Metabolic PPAR receptors and skin. Vnitr Lek. 2006;52(5):451-453.
Download citation

References

  1. Compe E, Egly JM. The DNA rapid/transcription factor TFIIH controls the transactivation by the peroxisome proliferator-activated receptors. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 12.
  2. Di-Poi N, Michalik L, Tan NS et al. The anti-apoptotic role of PPAR β contributes to efficient skin wound healing. J Steroid Biochem Mol Biol 2003; 85: 257-265. Go to original source... Go to PubMed...
  3. Haluzík M, Svačina Š. Metabolický syndrom a jaderné receptory PPAR. Praha: Grada Publishing 2005.
  4. Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003; 149: 229-236. Go to original source... Go to PubMed...
  5. Pershadingh HA et al. Novel PPSR γ ligands for topical treatment of inflamamatory and proliferative diseases of skin. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 11.
  6. Ruhl R et al. Inhibition of IGE production by PPAR ligands. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 45.
  7. Shulman AI, Mangelsdorf DJ Retinoid X Receptor Heterodimers in the Metabolic syndrome. N Engl J Med 2005; 353: 604-615. Go to original source... Go to PubMed...
  8. Smuth M et al. Differentiation and lipid accumulation in PPAR γ treated keratinocytes. Proceedings of 2nd International symposium on PPARs. Florencie: Fondazionne Giovanni Lorenzini 2003: 12.
  9. Tan NS et al. Peroxisome proliferator-activated receptor (PPAR)-β as a target for wound healing drugs: what is possible? Am J Clin Dermatol 2003; 4: 523-530. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.